Raymond James Financial Inc. Takes Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Raymond James Financial Inc. bought a new position in Prestige Consumer Healthcare Inc. (NYSE:PBH) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 545,440 shares of the company’s stock, valued at approximately $42,593,000. Raymond James Financial Inc. owned 1.10% of Prestige Consumer Healthcare as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Kestra Investment Management LLC bought a new stake in Prestige Consumer Healthcare during the 4th quarter valued at approximately $27,000. CIBC Private Wealth Group LLC grew its holdings in Prestige Consumer Healthcare by 48.9% during the 4th quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company’s stock valued at $34,000 after buying an additional 152 shares in the last quarter. Headlands Technologies LLC purchased a new position in shares of Prestige Consumer Healthcare in the fourth quarter worth $40,000. GAMMA Investing LLC boosted its position in shares of Prestige Consumer Healthcare by 18.9% during the fourth quarter. GAMMA Investing LLC now owns 1,383 shares of the company’s stock worth $108,000 after acquiring an additional 220 shares during the last quarter. Finally, Huntington National Bank grew its stake in Prestige Consumer Healthcare by 133.2% during the fourth quarter. Huntington National Bank now owns 1,481 shares of the company’s stock valued at $116,000 after acquiring an additional 846 shares in the last quarter. 99.95% of the stock is owned by institutional investors.

Insider Activity

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 1,678 shares of the firm’s stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $90.00, for a total value of $151,020.00. Following the completion of the sale, the senior vice president now directly owns 17,157 shares in the company, valued at $1,544,130. This trade represents a 8.91 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 1.60% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. Raymond James raised Prestige Consumer Healthcare to a “moderate buy” rating in a research note on Thursday, December 19th. StockNews.com lowered shares of Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a report on Tuesday, April 8th. Royal Bank of Canada increased their price objective on shares of Prestige Consumer Healthcare from $96.00 to $97.00 and gave the company a “sector perform” rating in a research report on Friday, March 21st. Canaccord Genuity Group boosted their target price on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a “buy” rating in a report on Friday, February 7th. Finally, Oppenheimer increased their price target on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an “outperform” rating in a report on Thursday, February 13th. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $93.33.

Prestige Consumer Healthcare Trading Down 1.5 %

PBH opened at $80.90 on Wednesday. The company has a debt-to-equity ratio of 0.56, a quick ratio of 2.20 and a current ratio of 3.68. The stock’s 50 day moving average price is $84.56 and its 200-day moving average price is $79.97. Prestige Consumer Healthcare Inc. has a one year low of $62.35 and a one year high of $90.04. The stock has a market cap of $4.01 billion, a price-to-earnings ratio of 18.95, a P/E/G ratio of 2.69 and a beta of 0.47.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings results on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. On average, equities analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.